Bio-Actives from Natural Products with Potential Cardioprotective Properties: Isolation, Identification, and Pharmacological Actions of Apigenin, Quercetin, and Silibinin.
Ekaterina-Michaela TomouParaskevi PapakyriakopoulouHelen SkaltsaGeorgia ValsamiNikolaos P E KadoglouPublished in: Molecules (Basel, Switzerland) (2023)
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide. As a result, pharmaceutical and non-pharmaceutical interventions modifying risk factors for CVDs are a top priority of scientific research. Non-pharmaceutical therapeutical approaches, including herbal supplements, have gained growing interest from researchers as part of the therapeutic strategies for primary or secondary prevention of CVDs. Several experimental studies have supported the potential effects of apigenin, quercetin, and silibinin as beneficial supplements in cohorts at risk of CVDs. Accordingly, this comprehensive review focused critically on the cardioprotective effects/mechanisms of the abovementioned three bio-active compounds from natural products. For this purpose, we have included in vitro, preclinical, and clinical studies associated with atherosclerosis and a wide variety of cardiovascular risk factors (hypertension, diabetes, dyslipidemia, obesity, cardiac injury, and metabolic syndrome). In addition, we attempted to summarize and categorize the laboratory methods for their isolation and identification from plant extracts. This review unveiled many uncertainties which are still unexplored, such as the extrapolation of experimental results to clinical practice, mainly due to the small clinical studies, heterogeneous doses, divergent constituents, and the absence of pharmacodynamic/pharmacokinetic analyses.
Keyphrases
- cardiovascular risk factors
- metabolic syndrome
- cardiovascular disease
- type diabetes
- clinical practice
- insulin resistance
- blood pressure
- uric acid
- physical activity
- weight loss
- left ventricular
- cardiovascular events
- weight gain
- heart failure
- glycemic control
- mesenchymal stem cells
- cell therapy
- high fat diet induced
- skeletal muscle
- plant growth